We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Cts4.2
Chitosan Research
Likely helps
9 peer-reviewed studies
What the evidence says
Likely helps
Chitosan appears to help in 6 of 6 studies with measurable effects — the evidence leans clearly favourable.
Most evidence is from high-quality meta-analyses and randomised trials published 2004–2024 with a typical study size of 1,130 participants.
Based on 9 studies · 6 meta-analyses · 4,637 total participants
Confidence
High confidence
What the studies found
6helped· 3 more without graded effect data
By outcome
Weight managementSmall weight and body-fat reduction (~0.8-1.7 kg in trials); effect shrinks in higher-quality studies and is unlikely to be clinically meaningful on its own · 8-12 weeks
Likely helps7 studies
Cholesterol & lipidsModest total-cholesterol reduction; effect on LDL is inconsistent · 8-12 weeks
Mostly mechanism / observational3 studies
Lean body mass & muscle growth
Too few graded studies2 studies
Heart & blood pressureModest total-cholesterol reduction; effect on LDL is inconsistent · 8-12 weeks
Too few graded studies1 study
Glucose & metabolicSmall reductions in fasting glucose and HbA1c reported at 1.6-3 g/day for 13+ weeks in metabolic-syndrome populations · 12+ weeks
Too few graded studies1 study
Safety profile
Too few graded studies1 study
By the numbers
Pulled from 9 studies with measurable effects
Likely real effects
100%
across studies
People studied
4,637
typical study: 1130 people
Strongest designs
6
6 pooled, 0 randomised
Showed benefit
100%
6/6 studies
Populations Studied
Overweight and obese adults3
Adults, mostly overweight/obese1
Adults1
Adults with metabolic syndrome / diabetes1
Steady research
2 studies in the last 5 years · Latest meta-analysis: 2024
200420142024
1Body weight reductionMeta-Analysisn=1,219 · large study2008
In plain English: Results obtained from high quality trials indicate that the effect of chitosan on body weight is minimal and unlikely to be of clinical significance.
Jull AB, Ni Mhurchu C, Bennett DA, Dunshea-Mooij CA, Rodgers A · Cochrane Database of Systematic Reviews (2008)
Noticeable benefit
← WorseNo effectBetter →
Fifteen randomized controlled trials with 1219 participants met the inclusion criteria.
Pooled analysis showed a statistically significant greater weight loss with chitosan (weighted mean difference -1.7 kg; 95% CI -2.1 to -1.3; P < 0.00001), plus small decreases in total cholesterol and blood pressure.
When analyses were restricted to trials that met allocation-concealment criteria, were larger, or of longer duration, the decreases in weight and total cholesterol were substantially smaller.
2Body weight and body compositionMeta-Analysisn=1,130 · large study2020
In plain English: Our findings provided evidence that chitosan consumption might be a useful adjunctive pharmacological therapeutic tool for body weight management particularly in overweight/obese participants.
Huang H, Liao D, Zou Y, Chi H · Critical Reviews in Food Science and Nutrition (2020)
Noticeable benefit
← WorseNo effectBetter →
Likely real
Fifteen eligible trials (18 treatment arms) with 1130 subjects were pooled using random-effects models with trial sequential analysis.
Chitosan significantly reduced body weight (WMD -0.89 kg; 95% CI -1.41 to -0.38; P = 0.0006), BMI (WMD -0.39 kg/m2; P = 0.002) and body fat (WMD -0.69%; P = 0.0001).
Subgroup analyses showed effects were larger at doses above 2.4 g/day, in shorter trials (<12 weeks), and in overweight/obese participants.
3Obesity indicators (weight, body fat, BMI, waist circumference)Meta-Analysis2024
In plain English: Chitosan supplementation shows promise in improving obesity indicators by reducing BFP and increasing FFM. However, further well-designed studies with larger sample sizes are needed to confirm these findings.
Kholdebarin M, Pahlavani N, Nikbaf-Shandiz M, et al. · Food Science & Nutrition (2024)
Noticeable benefit
← WorseNo effectBetter →
Likely real
Nineteen RCTs contributing 21 effect sizes were combined using random-effects models.
Chitosan significantly reduced body weight (WMD -0.79 kg; 95% CI -1.30 to -0.29; P = 0.002) and body-fat percentage (WMD -0.41%; P < 0.001), and modestly increased fat-free mass (WMD +0.20 kg; P = 0.005).
There was no significant effect on BMI (WMD -0.35 kg/m2; P = 0.054) or waist circumference (WMD -0.71 cm; P = 0.069).
4Fasting glucose and HbA1cMeta-Analysisn=1,473 · large study2020
In plain English: The glucose level of patients who are diabetic and obese/overweight can be improved by supplementation with chitosan for at least 13 weeks at 1.6-3 g per day.
Guo W, Yi L, Zhou B, Li M · Nutrition Journal (2020)
Noticeable benefit
← WorseNo effectBetter →
Ten randomized controlled trials with 1473 subjects were pooled with random-effects meta-analysis and trial sequential analysis.
Chitosan significantly reduced fasting glucose (SMD -0.39 mmol/L; 95% CI -0.62 to -0.16) and HbA1c (SMD -1.10; 95% CI -2.15 to -0.06), but did not affect insulin levels.
Subgroup analyses found significant fasting-glucose reductions at 1.6-3 g/day and in studies lasting longer than 13 weeks.
5Serum lipids (total cholesterol)Meta-Analysisn=416 · medium study2009
In plain English: Based upon the currently available literature, we can only say that chitosan beneficially affects total cholesterol with 95% confidence.
Baker WL, Tercius A, Anglade M, White CM, Coleman CI · Annals of Nutrition & Metabolism (2009)
Noticeable benefit
← WorseNo effectBetter →
Likely real
Six randomized, placebo-controlled trials in hypercholesterolemic patients (n = 416) were meta-analyzed.
Chitosan significantly lowered total cholesterol (WMD -11.59 mg/dL; 95% CI -21.45 to -1.73; P = 0.02).
It did NOT significantly change LDL cholesterol, HDL cholesterol, or triglycerides.
6Body-weight reduction across dietary supplementsSystematic Review2004
In plain English: The evidence for most dietary supplements as aids in reducing body weight is not convincing. None of the reviewed dietary supplements can be recommended for over-the-counter use.
Pittler MH, Ernst E · The American Journal of Clinical Nutrition (2004)
A systematic review of five prior systematic reviews/meta-analyses and 25 additional double-blind RCTs covering chitosan, glucomannan, chromium, Garcinia and other weight-loss supplements.
The reviewed studies provided some encouraging data but no evidence beyond reasonable doubt that any specific supplement, including chitosan, is effective for reducing body weight.
9Efficacy and safety of complementary weight-loss therapiesReview2021
In plain English: The evidence is still relatively limited and not encouraging to provide a definitive conclusion due to the methodological shortcomings and the presence of adverse events in chitosan and fiber supplementation.
Lua PL, Roslim NA, Ahmad A, Mansor M, Aung MMT, Hamzah F · Journal of Evidence-Based Integrative Medicine (2021)
A narrative review of eight systematic reviews/meta-analyses and 11 additional RCTs (765 participants) evaluating complementary weight-loss therapies.
Chitosan, spirulina, probiotics, EPA+DHA, vitamin D, fiber and herbal extracts were each associated with only small reductions in body weight (roughly 1-10 kg across heterogeneous studies).
They concluded the evidence is limited and not encouraging enough for a definitive recommendation.